Engineered Cell‐Derived Vesicles Displaying Targeting Peptide and Functionalized with Nanocarriers for Therapeutic microRNA Delivery to Triple‐Negative Breast Cancer in Mice-Reference-Cited by-同舟云学术

Engineered Cell‐Derived Vesicles Displaying Targeting Peptide and Functionalized with Nanocarriers for Therapeutic microRNA Delivery to Triple‐Negative Breast Cancer in Mice

Published:2021-12-17 Issue: Volume: Page:2101387
ISSN:2192-2640
Container-title:Advanced Healthcare Materials
language:en
Short-container-title:Adv Healthcare Materials

Author:

Bose Rajendran JC¹²,Kumar Uday Sukumar¹²,Garcia‐Marques Fernando¹,Zeng Yitian³,Habte Frezghi¹²,McCarthy Jason R⁴,Pitteri Sharon²,Massoud Tarik F¹,Paulmurugan Ramasamy¹²^ORCID

Affiliation:

1. Molecular Imaging Program at Stanford (MIPS) and Bio‐X Program Department of Radiology School of Medicine Stanford University Stanford CA 94305–5427 USA

2. Canary Center at Stanford for Cancer Early Detection Department of Radiology School of Medicine Stanford University Stanford CA 94305–5427 USA

3. Department of Materials Science and Engineering Stanford University Stanford CA 94305‐4034 USA

4. Biomedical and Translational Medicine Masonic Medical Research Institute Utica NY 13501 USA

Funder

Focused Ultrasound Foundation

National Institutes of Health

School of Medicine, Stanford University

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biomaterials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adhm.202101387

Reference46 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: The California Cancer Registry, 1999–2004

3. Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies

4. Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up

5. The evolving translational potential of small extracellular vesicles in cancer

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tailoring of apoptotic bodies for diagnostic and therapeutic applications:advances, challenges, and prospects;Journal of Translational Medicine;2024-09-01

2. Tumor Microenvironment‐Responsive Polymer‐Based RNA Delivery Systems for Cancer Treatment;Small Methods;2024-05-28

3. Engineered exosomes in emerging cell-free therapy;Frontiers in Oncology;2024-03-26

4. Unlocking the potential of exosomes in cancer research: A paradigm shift in diagnosis, treatment, and prevention;Pathology - Research and Practice;2024-03

5. Effects of extracellular vesicle-derived noncoding RNAs on pre-metastatic niche and tumor progression;Genes & Diseases;2024-01